₹4729.2▲0.06%
0.30%
Low
Day's Volatility:0.91%
High
0.61%
3.26%
Low
52 Weeks Volatility:22.58%
High
19.32%
Returns % | |
1 Month Return | -1.15 % |
3 Month Return | -10.22 % |
1 Year Return | 0.82 % |
Market Stats | |
Previous Close | ₹4,726.40 |
Open | ₹4,750.05 |
Volume | 3,971.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹7,845.82Cr |
Organisation | Procter & Gamble Health Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Procter & Gamble Health Ltd
Procter & Gamble Health Ltd recorded a surge in volume on NSE, with 55,916 shares traded by 14:14 IST, which is 3.57 times the two-week average daily volume of 15,650 shares. The stock lost 1.04% to close at Rs.4,820.00, with volumes standing at 68,743 shares in the last session.
Procter & Gamble Health Plans to Expand VMS Range - 19 Mar, 2024
Procter & Gamble Health is set to expand its portfolio of vitamins, minerals, and supplements (VMS), focusing on neurotrophic vitamins, as part of its five-year strategy. The company's stock volume surged 8.44 times over the two-week average daily volume on NSE.
Procter & Gamble Health Plans to Expand VMS Portfolio - 18 Mar, 2024
Procter & Gamble Health Ltd is set to expand its portfolio of vitamins, minerals, and supplements (VMS), particularly neurotrophic vitamins, under a five-year plan. The company has allocated funds for innovation and growth in the country, including increasing volumes of injectables through contract development and manufacturing organization (CDMO). Sales remained nearly unchanged YoY at ₹304 crore for Q4 2023 due to an overall slowdown in the VMS category.
Fundamentals of Procter & Gamble Health Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 27.92% to 28.21% in Mar 2024 quarter
MF Holding Up
Mutual Funds have increased holdings from 8.98% to 9.86% in Mar 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 51.82% of holdings in Mar 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.9% return, outperforming this stock by 158.0%
Against Peers
In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 51.6% return, outperforming this stock by 50.8%
FII Holding Down
Foreign Institutions have decreased holdings from 7.59% to 6.24% in Mar 2024 quarter
Price Dip
In the last 3 years, PGHL stock has moved down by -24.1%
Funds | Holdings |
Nippon India Small Cap Fund - Direct Plan - Growth Plan | 0.68% |
ICICI Prudential Smallcap Fund Direct Plan Growth | 2.01% |
UTI MNC Fund Direct Growth Option | 4% |
DSP Healthcare Fund Direct Growth | 3.18% |
Sundaram Small Cap Fund - Direct Plan - Growth Option | 1.19% |
Investors | Holdings % | Prev. 1 periods | 3M change |
---|---|---|---|
Promoter Holdings | 51.82% | 0.00 | |
Foreign Institutions | 6.24% | 0.00 | |
Mutual Funds | 9.86% | 0.00 | |
Retail Investors | 28.21% | 0.00 | |
Others | 3.86% | 0.00 |
Technicals of Procter & Gamble Health Ltd share
News & Events of Procter & Gamble Health Ltd
Procter & Gamble Health Ltd (PGHL) share price today is ₹4729.2
Procter & Gamble Health Ltd is listed on NSE
Procter & Gamble Health Ltd is listed on BSE
Today’s traded volume of Procter & Gamble Health Ltd(PGHL) is 3,971.00.
Today’s market capitalisation of Procter & Gamble Health Ltd(PGHL) is ₹7845.82Cr.
Procter & Gamble Health Ltd(PGHL | Price |
---|---|
52 Week High | ₹5642.85 |
52 Week Low | ₹4575 |
Procter & Gamble Health Ltd(PGHL) share price is ₹4729.2. It is down -16.19% from its 52 Week High price of ₹5642.85
Procter & Gamble Health Ltd(PGHL) share price is ₹4729.2. It is up 3.37% from its 52 Week Low price of ₹4575
Procter & Gamble Health Ltd(PGHL | Returns |
---|---|
1 Day Returns | 2.8% |
1 Month Returns | -1.15% |
3 Month Returns | -10.22% |
1 Year Returns | 0.82% |